What Propelled These 10 Firms’ Double-Digit Gains?

6. DexCom, Inc. (NASDAQ:DXCM)

Dexcom Inc. surged by 16.17 percent on Friday to end at $81.62 apiece after reporting an impressive 12.49 percent revenue growth in the first quarter of the year and maintaining outlook guidance for the rest of 2025.

In a statement, DexCom, Inc. (NASDAQ:DXCM) said that revenues improved to $1.036 billion in the past three months from the $921 million registered in the same period last year.

Net income, however, declined by 28 percent to $105.4 million from $146.4 million in the same comparable period.

“As we progress through 2025, we will advance our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for expanded global access to our glucose biosensors,” said DexCom, Inc. (NASDAQ:DXCM) CEO Kevin Sayer.

Looking ahead, the company expects full-year revenues to increase by 14 percent to $4.6 billion, and adjusted EBITDA margin to expand by 30 percent year-on-year.